Oncology

If you are a distributor of Oncology products, please inquire with us about product registration, importing and/or marketing our Oncology products in your country or region. If you are a consumer of our Oncology products, please contact us for additional product information.

Letrozole Tablets

    • Product Information Letrozole Tablet is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.  Letrozole decreases the amount of estrogen produced by the body. This can slow or stop the growth of some breast tumors that need estrogen to grow.

      Letrozole is used in women who have experienced menopause with any of the following types of breast cancer:

      •    Early-stage, hormone receptor positive (HR+) breast cancer in women who
           have already received other treatment.
      •    Early-stage breast cancer that has been treated with tamoxifen for at least
           five years.
      •    Breast cancer that is locally advanced or has metastasized (spread to other
           parts of the body) and is hormone receptor positive (HR+).
      •    Breast cancer that is locally advanced or has metastasized and it is not
           known whether the cancer is HR+ or hormone receptor negative (HR-).
      •    Advanced breast cancer that has gotten worse after antiestrogen  therapy.
    • Product Packaging This product is available in the following dosages:
      Letrozole Tablets 2.5mg

      Letrozole Tablets are available in the following packaging:
      10 tablets / blister, 10 blisters / box;
      or according to the customer's specifications.
    • Therapy Anticancer, Antineoplastic
    • Active Ingredients Letrozole
Get the Latest PRICE UPDATES delivered direct to your inbox